We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Standigm Inc. announced that they had successfully found a new arthritis indication for an FDA-approved drug and filed a patent. This is the first successful result of their open innovation partnership, formed in July 2019.